State Street’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-30,017
Closed -$36.3K 4532
2023
Q3
$36.3K Hold
30,017
﹤0.01% 4351
2023
Q2
$52.5K Hold
30,017
﹤0.01% 4407
2023
Q1
$50.4K Hold
30,017
﹤0.01% 4499
2022
Q4
$89.8K Buy
30,017
+5,800
+24% +$22.8K ﹤0.01% 4399
2022
Q3
$106K Hold
24,217
﹤0.01% 4449
2022
Q2
$97K Buy
24,217
+800
+3% +$3.06K ﹤0.01% 4553
2022
Q1
$93K Buy
+23,417
New +$87.2K ﹤0.01% 4663

State Street's MIRO Position: Q4 2023 in Review

State Street sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 30,017 shares — an estimated $36.3K sold.

State Street first reported a position in MIRO in Q1 2022 and held it in 7 quarters. The position peaked at $106K in Q3 2022. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

  • State Street reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • State Street sold 30,017 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $36.3K.
  • State Street first reported a position in Miromatrix Medical Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • State Street's Miromatrix Medical Inc. Common Stock position peaked at $106K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.